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The isoprenoid pathway is responsible for the generation of a wide range of products that are crucial for cellular processes; namely, cholesterol
synthesis, protein glycosylation, growth control and synthesis of several hormones. Farnesyl diphosphate synthase (FPS), a key enzyme in this
pathway, is usually considered to be cytosolic/peroxisomal. However, significant enzymatic activity has also been detected in rat liver
mitochondria, although none of the mammalian FPS genes characterized to date contain sequences coding for mitochondrial transit peptides. Here,
we describe the genomic organization of the human FPS gene and demonstrate that one of the two mRNAs expressed from this gene encodes an
isoform with a 66 amino acid N-terminal extension containing a peptide that targets it to mitochondria. Previous studies suggested that the N-
terminal extension of FPS in the plant Arabidopsis thaliana contains a mitochondrial targeting sequence. In this study, database analysis reveals
that this is also the case in a number of mammals and insects. Finally, we provide functional proofs that the N-terminal sequence of Drosophila
melanogaster FPS targets the protein to mitochondria. Taken together, these data suggest that mitochondrial targeting of FPS may be widespread
among eukaryotes.
© 2006 Elsevier B.V. All rights reserved.Keywords: Isoprenoid; Cholesterol; Juvenile hormone; Mitochondria; Drosophila1. Introduction
Farnesyl diphosphate synthase (FPS; EC 2.5.1.1/EC 2.5.1.10)
catalyzes the sequential 1′–4 condensation of two molecules of
isopentenyl diphosphate with the allylic phosphates dimethy-
lallyl diphosphate and geranyl diphosphate to produce the 15-
carbon prenyl diphosphate farnesyl diphosphate [1]. This
compound is a key intermediate in the isoprenoid biosynthetic
pathway, since it is the common precursor of a variety of
essential isoprenoid end products, including sterols, dolichols,
and the isoprenoid moieties of ubiquinone, heme a, andAbbreviations: DmFPS, Drosophila melanogaster farnesyl diphosphate
synthase; EGFP, enhance green fluorescent protein; FPS, farnesyl diphosphate
synthase; GP, gold particles; HsFPS, human farnesyl diphosphate synthase;
WSR, mutant strain of Saccharomyces cerevisiae carrying a disrupted COXIV
gene
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involved in isoprenoid biosynthesis has been the subject of
debate in recent years. It is generally accepted that in mammals,
peroxisomes play a central role in isoprenoid/cholesterol
biosynthesis, since the enzymes required to synthesize farnesyl
diphosphate from acetyl-CoA have been localized predomi-
nantly in these organelles. However, it has recently been claimed
that mevalonate kinase and mevalonate pyrophosphate decar-
boxylase are exclusively cytosolic enzymes, at least in humans
[2,3]. These results, together with the observation that
cholesterol biosynthesis is unaffected in human fibroblasts
defective for peroxisome biogenesis, led scientists to challenge
the dogma of the central role of peroxisomes in mammalian
isoprenoid/cholesterol biosynthesis [4].
Although it does not contain any peroxisome targeting
sequences, FPS has been reported to be predominantly
peroxisomal in a number of mammalian cells [5]. Nevertheless,
controversy still remains over its precise subcellular localiza-
tion, as well as the possibility that significant amounts of the
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evidence in favour of mitochondrial localization of FPS was
obtained in immunofluorescence or immunoelectron microsco-
py studies [6], subcellular fractionation and enzyme activity
assays showed that in rat liver up to 13% of total cellular FPS
activity is contained within mitochondria [7]. In contrast to the
situation in animals, indirect evidence of FPS localization in
mitochondria of plants has been provided. The genome of Ar-
abidopsis thaliana contains two genes (FPS1 and FPS2; [8])
encoding three FPS isoforms (FPS1S, FPS1L, and FPS2), one
of which (FPS1L) has an N-terminal extension of 41 amino
acids that has been shown to be a mitochondrial transit peptide
[9]. However, the prevailing view is that mammalian genomes
contain a single functional gene coding for FPS [10]. This raises
the possibility that a single gene encodes more than one
isoform, each of which could be localized and function in
different cellular compartments.
Given that the precise subcellular distribution of FPS in
mammals is still a matter of debate, particularly in terms of its
putative mitochondrial localization, we examined whether
mammals also contain a mitochondrial FPS isoform. In this
paper, we describe the genomic organization and splicing
pattern of the 5′ region of the human FPS (HsFPS) gene, and
demonstrate that one of the two mRNA species transcribed from
this gene encodes an FPS isoform that is efficiently targeted to
mitochondria. Moreover, we demonstrate the presence of
putative mitochondrial targeting peptides in the N-terminal
extension of FPS from several mammals and insects, and show
that the N-terminal extension of FPS from Drosophila
melanogaster conveys a passenger protein into mitochondria.
Taken together, these data suggest that FPS targeting to
mitochondria is widespread in eukaryotes.
2. Materials and methods
2.1. Sequence comparisons and analysis
The software package designed by the Genetics Computer Group of the
University of Wisconsin [11] was used for sequence alignments and second-
ary structure prediction. Putative mitochondrial targeting sequences were
predicted with the TargetP [12] and Predator (http://www.inra.fr/predator/)
programs.
2.2. Mapping of the 5′-end of HsFPS and DmFPS mRNAs
The 5′-end of the HsFPS and D. melanogaster FPS (DmFPS) mRNAs were
determined by 5′RACE, using the FirstChoice™RLM-RACE kit (Ambion) and
Drosophila S2 cells as a source of RNA. For HsFPS, the reverse primers used
were as follows: outer primer (HUMO) 5′-CGGAATGCTACTACCACCGT-
CAA-3′ (positions 1,731,921 to 1,731,943 from contig NT_004487), and inner
primer (HUMI), 5′-CGCGGATCCGAGCCGGGCAATAGCATCTCCTA-3′
(1,729,801 to 1,729,823). Nested reverse primers used to amplify the 5′-end of
the cDNA corresponding to the mitochondrial isoform were as follows: outer
primer (HUMITO), 5′-TTCCTCTGTCCACGCTTGGCA-3′ (1,729,564 to
1,729,584), and inner primer (HUMITI), 5′-CGCGGATCCGTCCACGCTTGG-
CACCAGCA-3′ (1,729,558 to 1,729,577). BamHI restriction sites are under-
lined. In the case of DmFPS, the reverse primers were as follows: outer primer
(Dro1), 5′-TCCATCACATCGTCTGAGATGAT-3′ (positions 590 to 611 from
sequence AF132554), and inner primer (Dro2), 5′-ACTTTGGAGCATTTC-
CACGCACCA-3′ (560–583). In both cases, amplified fragments were cloned
into pBluescript and sequenced.2.3. Reverse transcription-PCR analysis
To detect the HsFPS cDNA that includes the mitochondrial targeting
peptide, RNA from HepG2, CaCo-2, HT29 and HeLa human cells [13] was
used. RNA was isolated with the GenElute™ Mammalian Total RNA kit
(Sigma), and cDNAwas obtained as described previously [14]. Primers used for
detection of the HsFPS cDNA that includes the mitochondrial targeting peptide
were as follows: forward, 5′-ATGCCCCTGTCCCGCTGGTTGAGATCT-3′,
and reverse, 5′-CTGAGGGAGGAGCAAAGGGCTCGAGGT-3′, encompass-
ing amino acids 1–9 and 58–66, respectively, according to the sequence
represented in Fig. 3. To amplify the DmFPS cDNA containing the
mitochondrial targeting peptide we followed the same procedure, using Dro-
sophila S2 cells as RNA source, and primers were as follows: forward, 5′-
ATGTTTAAACTGGCCCGTATCCTC-3′, and reverse, 5′-ACTTTGGAG-
CATTTCCACGCACCA-3′ encompassing amino acids 1–8 and 73–81,
respectively, according to the sequence represented in Fig. 3. D. melanogaster
ribosomal protein 49 (Rp49) was used as a control for amplification and loading.
2.4. Green fluorescent protein fusion constructs
Plasmid HsFPS(tp)-EGFP contains the first 66 amino acids of the HsFPS
protein fused in with EGFP. The sequence coding for the putative targeting
peptide was obtained by PCR using the primer pair 5′-ATAAAGCTTAT-
GCCCCTGTCCCGCTGGTTGAGATCT-3′ (forward) and 5′-ATAACC-
GGTTTTCTGAGGGAGGAGCAAAGGGCTCGAGGT-3′ (reverse). HindIII
and AgeI restriction sites (underlined) were added to facilitate cloning of the
fragments into the pEGFP-N1 vector (Clontech). The resulting plasmid,
HsFPS(tp)-EGFP, expressed the fusion protein under the control of the CMV
promoter. The pEGFP-N1 plasmid, expressing the native EGFP protein, was
used as a control.
To construct DmFPS(tp)-EGFP, containing D. melanogaster FPS(tp), the
sequence coding for the first 80 amino acids of the DmFPS was PCR amplified
using primers that contained AgeI restriction sites (underlined): 5′-ATA-
ACCGGTATGTTTAAACTGGCCCGTATCCTC-3′ (forward) and 5′-ATA-
ACCGGTTTCGACACCGTGACGCGAGCGGCAAT-3′ (reverse). Prior to
amplification, a PCR-based site directed mutagenesis was used to change the
Met residues at positions 7 and 40 to Ile, using the mutagenic complementary
primer pair 5′-ATCAAGTCCATCGACACCATT-3′ (forward) and 5′-AATGG-
TGTCGATGGACTTGAT-3′ (reverse), and also using the mutated initial
forward primer (mutations within the primers are underlined). The amplified
fragment was cloned into the pEGFP-N1 plasmid. Afterwards, the 1050 base
pair fragment containing DmFPS(tp) fused to EGFP was subcloned into the
pAc5/V5-His(C) plasmid (Invitrogen) just downstream of the D. melanogaster
actin5C promoter. As a control, plasmid pAc5-EGFP was constructed by
subcloning the entire EGFP sequence from the pEGFP-N1 plasmid into pAc5/
V5-His(C) plasmid. This construct expressed the EGFP protein under the
control of D. melanogaster actin5C promoter. Preparation of all constructs was
confirmed by restriction analysis and sequencing.
2.5. Cell culture and confocal microscopy
Human HeLa and D. melanogaster S2 cells were maintained and transfected
as described elsewhere [15,16]. Forty-eight hours after transfection, HeLa and
S2 cells were placed in fresh medium containing 100–500 nM of the
mitochondria-specific stain MitoTracker Red CMXRos (Molecular Probes)
and incubated for 15–30 min. Cells were examined with appropriate filters on a
Leica TCS confocal laser scanning microscope (Heidelberg, Germany).
2.6. Immunoelectron microscopy
HeLa cells were fixed and embedded in Lowicryl K4M. Ultrathin sections
(50–70 nm) were obtained with a Leica Ultracut UCT ultramicrotome. For
immunolabeling, a polyclonal antibody raised in rabbit against rat FPS (a gift of
P. Edwards, UCLA) was used at a dilution of 1:500, and gold-conjugated goat
anti-rabbit IgG was used as the secondary antibody at a dilution of 1:25. Control
treatments using the secondary antibody alone were carried out in parallel.
Sections were examined on a Jeol 1010 transmission electron microscope at
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selected at random from the same cell ×10 cells studied). These micrographs
were taken at a magnification between ×20,000 and ×30,000, and immunolabel-
ing was quantified by counting the gold particles observed in each cell
compartment. An equivalent series of 50 micrographs of control cells, treated
only with the secondary antibody, were also studied.
2.7. Functional complementation of mutant yeast
DNA fragments from D. melanogaster encoding putative targeting peptides
of two different lengths, from Met 1 to Ser 80 and from Met 40 to Ser 80, were
generated by RT-PCR and cloned in frame into the corresponding sites of
plasmid pYΔCOX, which contains a truncated yeast COXIV (lacking the
presequence) gene under the control of the alcohol dehydrogenase promoter,
yielding plasmids pDm1-ΔCOX and pDm2-ΔCOX. The WSR mutant strain of
Saccharomyces cerevisiae was used. This strain carries a disrupted COXIV gene
encoding the CoxIV subunit of mitochondrial cytochrome c oxidase and cannot
grow in medium containing glycerol as energy source [17]. Transformation of
the WSR strain with pYCOX, pYΔCOX, pDm1-ΔCOX, or pDm2-ΔCOX, and
functional complementation assays were carried out as described elsewhere
[9,18].
3. Results
3.1. The human FPS gene encodes a putative mitochondrial
isoform
A cDNA sequence coding for HsFPS has been reported
previously [19], although the authors stated that the deduced
protein might contain additional amino acids at the N-terminal
region, since there was no stop codon upstream of the
proposed ATG start codon. A search in the NCBI database
revealed the occurrence of a human sequence (accession
number, NM002004) containing an in-frame ATG codon
located 198 bp upstream of the previously reported HsFPS
start codon. Interestingly, conceptual translation from this
ATG gives rise to an FPS isoform with a N-terminal extension
of 66 amino acids when compared with the described HsFPS.
This extension contains a putative mitochondrial targeting
sequence, as determined by analysis with conventional
prediction algorithms (TargetP, Predator).
To precisely define the 5′-end of the HsFPS mRNAs we
performed 5′-RACE analysis. Using primers HUMO and
HUMI as nested PCR gene-specific primers (Fig. 1A), we
amplified two different sets of products ranging in size from 196
to 252 nt, and from 324 to 337 nt. Sequence alignment of these
fragments with the HsFPS gene (chromosome 1, contig
NT_079484) revealed the occurrence of mRNA species
containing the as yet unreported exon 1 as the most 5′ exon,
joined with the exon encoding the N-terminal region of the
previously described HsFPS [19] (further referred to here as
exon 3, Fig. 1A). This analysis also showed that the HsFPS
gene has multiple transcription start sites, with those located at
positions −136, −36 and −29 with respect to the first ATG
codon in exon 1 being the most frequently used (Fig. 1A).
Finally, results additionally indicated that the intervening
sequence between exons 1 and 3 can be spliced using alternative
5′donor (GT) sites (a and b), and 3′ acceptor (AG) sites (c and
d) (Fig. 1A). Nevertheless, sites a and c are preferentially used
as donor and acceptor sites, respectively. Interestingly, if donorsite b is used, then exon 1 contains 111 additional nucleotides,
including a short ORF coding for 32 amino acids that is located
in the 5′ untranslated region of the resulting mRNA (Fig. 1A).
The use of the alternative acceptor sites c and d also leads to
two forms of exon 3 differing in 21 nt, although in both cases
the resulting exon includes the ATG start codon of the cytosolic/
peroxisomal HsFPS [19]. Given that none of these mRNA
splice variants would include the sequence coding for the
putative mitochondrial targeting peptide identified in the
aforementioned cDNA (NM002004), additional 5′-RACE
experiments were carried out using a new pair of nested PCR
gene-specific primers, HUMITO and HUMITI, complementary
to sequences within the predicted exon 2 (Fig. 1A). Cloning and
sequencing of the PCR products revealed the amplification of a
set of fragments ranging in size from 225 to 335 nt. Alignment
of these sequences with the HsFPS gene demonstrated the
existence of novel mRNA splice variants in which exon 1 was
joined with the novel exon 2 located between exons 1 and 3
(Fig. 1A). Given that both 5′ donor sites (a and b) of intron 1
can be used to generate these transcripts, some of them also
contain the long version of exon 1 including the ORF in the 5′
untranslated sequence (Fig. 1A). As the sequence of exon 2
includes the aforementioned in-frame ATG codon upstream of
the first ATG codon in exon 3, these novel splice variants would
encode a longer novel FPS isoform with the predicted
mitochondrial targeting peptide of 66 amino acids (Fig. 1B).
The occurrence of transcripts encoding this novel isoform was
further confirmed by RT-PCR using primers in exons 2 and 3,
and RNA from human cell lines HepG2, CaCo-2, HT29, and
HeLa. A PCR product of the expected size (225 bp) was
detected in all samples (Fig. 1C). Taken together, all these
results indicate that HsFPS expression generates multiple
mRNA splice variants that encode two FPS isoforms: the
previously reported short isoform [19], which should be
cytosolic/peroxisomal, and a longer isoform with an N-terminal
extension that is likely to function as a mitochondrial targeting
peptide.
3.2. A Human FPS isoform is targeted to the mitochondria
To test the functionality of the targeting peptide, we first
engineered an EGFP fusion vector expressing the first 66 amino
acids of HsFPS, which should contain the putative mitochon-
drial targeting peptide, fused to the N-terminal end of EGFP.
This construct, HsFPS(tp)-EGFP, as well as the control plasmid
expressing EGFP itself, was transfected into HeLa cells and
fluorescence was examined by confocal microscopy (Fig. 1D).
In cells transfected with the control plasmid, green fluorescence
was visible throughout the entire cell, including the nucleus. In
contrast, cells expressing HsFPS(tp)-EGFP exhibited a net-
work-like fluorescence pattern, perfectly matching the staining
pattern of the mitochondria-specific dye MitoTracker Red
CMXRos (Fig. 1D). These results strongly suggest that the
N-terminal region of HsFPS functions as a mitochondrial tar-
geting peptide.
To confirm the occurrence of FPS within human mitochon-
dria, we examined its subcellular localization in HeLa cells by
Fig. 1. Expression of FPS in human cells and properties of the N-terminal extension as mitochondrial targeting sequence. (A) Genomic organization and splicing
pattern of the 5′ region of the HsFPS gene. Exons are shown as boxes and introns as lines. The most frequently used transcription start sites of HsFPS are indicated by
arrows. The conserved dinucleotides in the 5′ donor (GT) and 3′ acceptor (AG) splice sites of introns are shown. (a) and (b) indicate the two alternative donor sites of
intron 1 whereas (c) and (d) indicate the alternative acceptor sites of intron 2. Arrows located below the schematic representation of the HsFPS gene represent nested
gene-specific PCR primers (Humo/Humi and Humito/Humiti) used in 5′-RACE experiments. The two forms of exon 1 are represented by an open box (short form) and
by an open box joined with a blue box (long form). Translation start codons in exons 1, 2 and 3, and the stop codon in exon 1 are also indicated. The predicted protein
products are named to the right of the illustration. (B) Schematic representation of the N-terminal region of the HsFPS isoforms encoded by the mRNA splice variants
shown in panel A. The sequence encoded by exon 2 is represented as a brown box, and that encoded by exon 3 is shown as a yellow box. The positions of the initiator
Met residues for the mitochondrial and cytosolic/peroxisomal HsFPS isoforms are indicated, and the amino acid sequence of the predicted mitochondrial targeting
peptide is underlined. An asterisk indicates the last amino acid encoded by exon 2, and the initiator Met residue of the cytosolic/peroxisomal HsFPS is shown in green.
(C) RT-PCR analysis of mRNAvariants containing exon 2 in different human cell lines (HepG2, CaCo-2, HT29 and HeLa). An arrow indicates the position of the 225-
bp amplified fragment corresponding to mitochondrial HsFPS mRNA. Numbers on the right indicate the sizes in bp of DNA size markers in lane M. (D) Confocal laser
scanning micrographs showing the distribution of green fluorescence in HeLa cells transiently expressing a fusion of the HsFPS mitochondrial targeting peptide with
the EGFP (HsFPStp-EGFP) and EGFP alone. The pattern of red fluorescence obtained when HeLa cells were treated with the mitochondria-specific dye MitoTracker
Red CMXRos is also shown. The scheme of the constructs is shown below the fluorescence images.
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against rat FPS. Most HsFPS immunolabeling was detected in
the cytoplasm, either free (48% of the gold particles, GP) or
associated with the rough endoplasmic reticulum (11% GP)
(Fig. 2A). Then, significant HsFPS immunolabeling was also
observed in the mitochondria (26% GP), either within the
matrix or associated with the mitochondrial membrane (Fig. 2A,
B), and in the peroxisomes (12% GP). A small percentage of GP
(3%) was observed in the nucleus and in extracellular spaces,
which is taken to represent unspecific immunolabeling. In our
samples, mitochondria were more abundant than peroxisomes,
and the mean ratio of GP per organule was 1.17 in the case of
mitochondria, and 1.27 for peroxisomes. Control cells, treated
only with the secondary antibody, did not show any labeling.3.3. Occurrence of FPS proteins with mitochondrial transit
peptides is a widespread phenomenon in eukaryotes
Taken together with results reported for A. thaliana [9], the
data presented above suggest that mitochondrial localization of
FPS proteins is a general phenomenon in eukaryotes. To address
this hypothesis, we performed multiple sequence alignments of
the FPS proteins found in the literature and in databases. In this
way, N-terminal extensions were identified in a number of
mammals (in addition to Homo sapiens): Rattus norvegicus
(AY_321335) and Mus musculus (AK077979, not designated
as FPS); and insects: Agrotis ipsilon [20] (AJ009962), Bombyx
mori (BAB69490), Choristoneura fumiferana (AAY33486.1)
[21], Mythimna (=Pseudaletia) unipuncta (AAY33487.1)
Fig. 2. Electron micrographs of HeLa cells immunolabeled for FPS using a
polyclonal antibody against rat FPS. (A) Section showing HsFPS immunolo-
calization in mitochondria and in the cytoplasm, scattered and associated to
rough endoplasmic reticulum, (B) immunolocalization in the matrix of
mitochondria. Scale bars, 0.5 μm. Arrows indicate gold particles. M,
mitochondria; RER, rough endoplasmic reticulum.
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(AAY33488.1) [21], Ips pini (AAX55631.1) [22], Anthono-
mus grandis (AAX78434.1) [22], Dendroctonus jeffreyiFig. 3. Alignment of the 5′ region of a selection of farnesyl diphosphate synthase sequ
yeast S. cerevisiae (AAA34606) was included as a reference of a FPS without such e
initial Met (indicated in bold) of the strict FPS molecule. RXXS motifs, suggestive of
first RXXS motif that may form a positively charged amphiphilic α-helix are indica(AAX78435.1) [22], Anopheles gambiae (XP_308653, not
designated as FPS) and D. melanogaster (AF132554), in
addition to the plant A. thaliana (U80605). As in H. sapiens and
A. thaliana, the N-terminal extensions of the FPS of these
species are enriched in basic, hydroxylated and hydrophobic
residues, have at least one RXXS tetrapeptide, which is a
consensus cleavage motif in mitochondrial targeting peptides
[23], and contain sequence portions that may form a positively
charged amphiphilic α-helix. All of these features are typical of
mitochondrial targeting peptides. A selection of these sequences
have been included in Fig. 3, highlighting the features sugges-
tive of mitochondrial targeting peptides.
3.4. An insect FPS gene also encodes a mitochondrial
protein
Analysis of the D. melanogaster genome database revealed
the occurrence of a singleFPS gene (FlyBase ID: FBgn0025373),
as occurs in humans. It has a length of 2,064 nt, comprises six
exons, and encodes a predicted protein of 419 amino acids,
which would include the N-terminal extension predicted to
contain a mitochondrial targeting sequence (Fig. 4A). To
assess the occurrence of this sequence in a native protein
isoform, we first defined the structure of the 5′-end of the
DmFPS mRNA by 5′-RACE using two primers, one located at
a point within exon 4 (Dro1) and the other one at a point within
intron 3 (Dro2) (Fig. 4A). This generated a PCR product of
590 bp. Alignment of this sequence with that of the DmFPS
gene defined the 5′-end of the mRNA, and more importantly,
showed that it included the putative mitochondrial targeting
peptide located within exon 1 (Fig. 4A). Moreover, RT-PCR
analysis (with a primer pair designed to amplify a fragment
starting at a point within exon 1 and terminating at a point
within exon 3) showed that this DmFPS isoform is expressed
throughout the entire developmental cycle, being particularlyences from mammals, insects and a plant that show a N-terminal extension. The
xtension. These regions show a 65–113 amino acid extension with respect to the
mitochondrial targeting cleavage sequence, are underlined. Sequences before the
ted in grey.
Fig. 4. Expression of FPS in fruitfly cells and properties of the N-terminal extension as mitochondrial targeting sequence. (A) Genomic organization of the 5′ region of
theDmFPS gene. Different exons and introns as well as their size are indicated. Primers used in 5′-RACE as well as the transcription start site are shown by arrows. (B)
Expression of DmFPS containing the mitochondrial targeting peptide is detectable by RT-PCR throughout the whole development cycle. A band of the expected size
(243 bp) was obtained in every case. D. melanogaster Rp49 was used as a control for amplification and loading. (C) Functional complementation of a CoxIV-deficient
yeast strain, by plasmids pDm1- and pDm2-ΔCOX. Left: schematic representation of the plasmids used. Plasmid pYCOX contains the wild-type COXIV gene from S.
cerevisiae, including the region encoding its own mitochondrial targeting peptide (tp), which has been deleted in plasmid pYΔCOX. Plasmids pDm1-ΔCOX and
pDm2-ΔCOX contain putative targeting peptides Dm1 (from Met 1) and Dm2 (from Met 40) from N-terminal extension of fruitfly FPS, ligated upstream of the
partially deleted COXIV gene from yeast. Right: complementation analysis of yeast strain WSR transformed with the plasmids described above. Strains WSR, WSR
[pYΔCOX], WSR[pYCOX], WSR[pDm1-ΔCOX] and WSR[pDm2-ΔCOX] were streaked onto N3 medium containing glycerol as energy source, and incubated at
28 °C for 2 days. (D) Subcellular localization of the N-terminal fragment of the DmFPS (amino acids 1–80) fused to EGFP. Fluorescence images of S2 cells (right),
transiently transfected with the respective constructs (left). Cells expressing EGFP showed strong fluorescence in the nucleus and in the cytoplasm (“EGFP” panel)
whereas cells expressing the fusion protein showed a network-like fluorescence pattern (“DmFPS(tp)-EGFP” panel) virtually identical to that obtained with the
mitochondria-specific dye MitoTracker Red CMXRos (“Mitotracker” panel).
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high metabolic activity (Fig. 4B).
To determine whether the DmFPS N-terminal extension
functions as a mitochondrial targeting peptide, we studied its
ability to convey a passenger protein into mitochondria, using a
heterologous complementation assay in mutant WSR yeast [9].
We followed this approach first because the case of DmFPS is
more complex than that of HsFPS, given that DmFPS N-
terminal extension contains two in-frame Met and two RXXS
motifs, which cast doubts on the localization of the putative
mitochondrial targeting peptide. Therefore, the amino acid se-
quences from Met 1 (Dm1) and Met 40 (Dm2) to Ser 80, were
fused in frame with a trunctated S. cerevisiae COXIV gene
lacking the region coding for its own mitochondrial targeting
peptide (ΔCOXIV). The plasmids (pDm1-ΔCOX, pDm2-
ΔCOX; Fig. 4C) were then assayed for their ability to com-plement the mutant yeast strain WSR. Only pDm1-ΔCOX
restored the respiratory function of the WSR strain (Fig. 4C),
indicating that the yeast CoxIV subunit was effectively targeted
into yeast mitochondria by Dm1, and that the mitochondrial
targeting peptide is located between Met 1 and Met 40 of
DmFPS.
To assess the functionality of the DmFPS N-terminal
extension in an homologous system, we transfected Droso-
phila S2 cells with the DmFPS(tp)-EGFP fusion construct. This
construct contains an EGFP fusion of the first N-terminal 80
amino acids of DmFPS, with Met 40 and Met 7 mutated to Ile,
under the control of theD. melanogaster actin5C promoter (Fig.
4D). As a control, a plasmid expressing EGFP alone was also
transfected. Confocal microscopy revealed that in DmFPS(tp)-
EGFP-transfected cells fluorescence appears in a network-like
pattern virtually identical to that obtained with the specific
425D. Martín et al. / Biochimica et Biophysica Acta 1773 (2007) 419–426mitochondrial marker MitoTracker Red CMXRos. In contrast,
fluorescence is uniform throughout the whole cell in control,
EGFP-transfected cells (Fig. 4D).
4. Discussion
Traditionally, the enzyme FPS has been considered as
cytosolic/peroxisomal. However, the results of our database
analysis and 5′-RACE experiments indicate that transcription of
HsFPS gives rise to a heterogeneous population of mRNAs
encoding two FPS isoforms: the cytosolic/peroxisomal isoform,
which has been reported elsewhere [19], and a novel isoform
containing an N-terminal extension of 66 amino acids. This
previously unidentified isoform contains structural features
suggestive of a mitochondrial targeting peptide.
Our transfection and confocal microscopy studies showed
the ability of the N-terminal extension to convey a passenger
protein into mitochondria. In addition, our immunoelectron
microscopy observations indicated the occurrence of FPS
within the mitochondria. Taken together, these data demonstrate
for the first time that an HsFPS isoform has an N-terminal
extension containing a functional mitochondrial targeting
sequence, and that FPS localizes in human mitochondria.
These results are consistent with the FPS enzymatic activity
found in rat liver by Runquist et al. [7], and are at odds with
those of Krisans et al. [6], who reported an absence of FPS
localization in mitochondria analyzed by microscopy.
Although several enzymes of the presqualene segment of the
isoprenoid biosynthetic pathway have been reported to be
localized partially or totally in peroxisomes, Waterham and
colleagues have clearly established that functional peroxisomes
are not required for the normal functioning of such enzymes [4].
Indeed, in recent years three of these enzymes, mevalonate
kinase, mevalonate pyrophosphate decarboxylase and phos-
phomevalonate kinase, have been shown unambiguously to be
localized in the cytosol [2,3,24].
Interestingly, the structure of the 5′ region of the M.
musculus FPS gene (contig NT_039234) is similar to that of
HsFPS and, in fact, a cDNA sequence encoding a form of M.
musculus FPS containing a putative mitochondrial targeting
sequence is found in the NCBI database (AY399923). This
observation suggests that the complex splicing pattern in the 5′
region of HsFPS also occurs in other mammalian FPS genes,
and that mitochondrial targeting of FPS is not exclusive to
humans. Further literature searches and database analysis
revealed a number of lepidopteran, homopteran, coleopteran
and dipteran insect species in which FPS has an N-terminal
extension containing typical features of a mitochondrial tar-
geting peptide. This suggests that targeting of FPS to mitochon-
dria is widespread in eukaryotes. This hypothesis is further
supported by our functional analyses using the insect D.
melanogaster as a model system. The isoprenoid pathway in
insects has two relevant peculiarities: the absence of the sterol
branch, which makes insects unable to synthesize cholesterol de
novo, and the synthesis of juvenile hormone, an insect-specific
sesquiterpenoid molecule that regulates a number of physio-
logical processes, including embryogenesis, metamorphosis,and reproduction [25]. These two constraints have led to the
occurrence of specific regulatory mechanisms controlling the
whole pathway, and make insects an especially interesting
model in which to analyze the regulation of the mevalonate
pathway and its organization into subcellular compartments.
Our analyses in both yeast and Drosophila S2 cells indicate that
the N-terminal extension of FPS from D. melanogaster
functions to target the protein to mitochondria.
Previous studies based on WSR complementation assays
suggested that the N-terminal extension of FPS from the plant
A. thaliana contains a mitochondrial targeting sequence [9].
The data obtained here indicate that this is also true of some
vertebrate (mammals) and invertebrate (insects) animals, thus
suggesting that it is a general phenomenon in eukaryotes. The
machinery for protein import into mitochondria requires a
transit peptide that binds to receptors on the mitochondrial
surface, a membrane potential across the inner membrane, and
ATP to maintain the precursors in an unfolded state. When the
precursor has penetrated the mitochondrial matrix, the NH2-
extension is removed by additional processing machinery, and
the protein is directed to the corresponding submitochondrial
compartment [26,27]. Our results indicate that, for FPS, such an
exquisitely complex translocation system is conserved not only
in plants, but also in animals.
In both humans and fruit flies (present results), as in the plant
A. thaliana [9], FPS is an alternatively spliced gene, encoding
mitochondrial and non-mitochondrial isoforms. This is consis-
tent with the reported localization of FPS in peroxisomes in
mammal cells [5], which would be predicted to use the non-
mitochondrial isoform. Targeting of FPS to mitochondria may
offer greater versatility for regulation of the entire isoprenoid
pathway by subcellular compartmentalization. In particular, it
could facilitate a tighter regulation of those isoprenoid deriva-
tives that are needed in the mitochondrion itself, such as ubiqui-
none, the isoprenoid moiety of heme a, and prenylated proteins.
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